For: | Garbuzenko DV. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis . World J Clin Cases 2022; 10(12): 3662-3676 [PMID: 35647163 DOI: 10.12998/wjcc.v10.i12.3662] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i12/3662.htm |
Number | Citing Articles |
1 |
莉 田. Study on the Mechanism of Blood Circulation in Patients with Liver Fibrosis. Advances in Clinical Medicine 2022; 12(11): 9816 doi: 10.12677/ACM.2022.12111416
|
2 |
Qiying Pei, Qian Yi, Liling Tang. Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities. International Journal of Molecular Sciences 2023; 24(11): 9671 doi: 10.3390/ijms24119671
|
3 |
Mengqin Yuan, Lichao Yao, Ping Chen, Zheng Wang, Pingji Liu, Zhiyu Xiong, Xue Hu, Lanjuan Li, Yingan Jiang. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis. International Immunopharmacology 2023; 125: 111134 doi: 10.1016/j.intimp.2023.111134
|
4 |
Rui Tang, Jing Luo, Xiaoxia Zhu, Pengyu Miao, Hong Tang, Yue Jian, Sibei Ruan, Feng Ling, Mingxi Tang. Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1258870
|
5 |
Jea Il Kim, Hyae Gyeong Cheon. Melatonin ameliorates hepatic fibrosis via the melatonin receptor 2-mediated upregulation of BMAL1 and anti-oxidative enzymes. European Journal of Pharmacology 2024; 966: 176337 doi: 10.1016/j.ejphar.2024.176337
|
6 |
Qing-Qing Liu, Jing Chen, Tao Ma, Wei Huang, Cui-Hua Lu. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl4-induced liver fibrosis by suppressing Wnt/β-catenin signaling. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59698-w
|
7 |
Jianhao Jiang, Ilgiz Gareev, Tatiana Ilyasova, Alina Shumadalova, Weijie Du, Baofeng Yang. The role of lncRNA-mediated ceRNA regulatory networks in liver fibrosis. Non-coding RNA Research 2024; 9(2): 463 doi: 10.1016/j.ncrna.2024.01.001
|
8 |
Jin-Pei Liu, Shao-Hua Song, Pei-Mei Shi, Xiao-Yu Qin, Bai-Nan Zheng, Shu-Qing Liu, Chen-Hong Ding, Xin Zhang, Wei-Fen Xie, Yi-Hai Shi, Wen-Ping Xu. miR-541 is associated with the prognosis of liver cirrhosis and directly targets JAG2 to inhibit the activation of hepatic stellate cells. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03174-2
|
9 |
Xiaoxue Hou, Yuwen Li, Jiali Song, Linya Peng, Wen Zhang, Rui Liu, Hui Yuan, Tiantong Feng, Jieying Li, Wenting Li, Chuanlong Zhu. METTL14 reverses liver fibrosis by inhibiting NOVA2 through an m6A-YTHDF2–dependent mechanism. Hepatology Communications 2023; 7(8) doi: 10.1097/HC9.0000000000000199
|
10 |
Yiheng Zhang, Mulan Xing, Fansheng Meng, Ling Zhu, Qingchuan Huang, Tianle Ma, Huihua Fang, Xujing Gu, Suzhou Huang, Xinyu Wu, Gaohong Lv, Jun Guo, Li Wu, Xin Liu, Zhipeng Chen. The mechanical mechanism of angiotensin II induced activation of hepatic stellate cells promoting portal hypertension. European Journal of Cell Biology 2024; 103(2): 151427 doi: 10.1016/j.ejcb.2024.151427
|
11 |
Xiao-Xue Hou, Yu-Wen Li, Jia-Li Song, Wen Zhang, Rui Liu, Hui Yuan, Tian-Tong Feng, Zheng-Yi Jiang, Wen-Ting Li, Chuan-Long Zhu. Cryptotanshinone induces apoptosis of activated hepatic stellate cells <i>via</i> modulating endoplasmic reticulum stress. World Journal of Gastroenterology 2023; 29(17): 2616-2627 doi: 10.3748/wjg.v29.i17.2616
|
12 |
Weijing Lai, Bo Wang, Rongshuang Huang, Chuyue Zhang, Ping Fu, Liang Ma. Ferroptosis in organ fibrosis: From mechanisms to therapeutic medicines. Journal of Translational Internal Medicine 2024; 12(1): 22 doi: 10.2478/jtim-2023-0137
|
13 |
Irina Cardoso-Lezama, Erika Ramos-Tovar, Jaime Arellanes-Robledo, Eduardo E. Vargas-Pozada, Verónica Rocío Vásquez-Garzón, Saúl Villa-Treviño, Pablo Muriel. Serum α-SMA is a potential noninvasive biomarker of liver fibrosis. Toxicology Mechanisms and Methods 2024; 34(1): 13 doi: 10.1080/15376516.2023.2244061
|
14 |
Osama A. Mohammed, Mahmoud E. Youssef, Ahmed S. Doghish, Rabab S. Hamad, Mustafa Ahmed Abdel-Reheim, Mushabab Alghamdi, Mohannad Mohammad S. Alamri, Jaber Alfaifi, Masoud I.E. Adam, Muffarah Hamid Alharthi, Abdullah Hassan Alhalafi, Emad Bahashwan, Assad Ali Rezigalla, Daad Fuad BinAfif, Sameh Abdel-Ghany, Mohammed A. Attia, Elsayed A. Elmorsy, Tohada M. AL-Noshokaty, Heba Fikry, Lobna A. Saleh, Sameh Saber. A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis. European Journal of Pharmaceutical Sciences 2024; 198: 106792 doi: 10.1016/j.ejps.2024.106792
|